» Articles » PMID: 34288595

The Development of the Rheumatology Informatics System for Effectiveness Learning Collaborative for Improving Patient-Reported Outcome Collection and Patient-Centered Communication in Adult Rheumatology

Abstract

Objective: Patient-reported outcomes (PROs) are an integral part of treat-to-target approaches in managing rheumatoid arthritis (RA). In clinical practice, however, routine collection, documentation, and discussion of PROs with patients are highly variable. The RISE LC (Rheumatology Informatics System for Effectiveness Learning Collaborative) was established to develop and share best practices in PRO collection and use across adult rheumatology practices in the United States METHODS: The goals of the RISE LC were developed through site surveys and in-person meetings. Participants completed a baseline survey on PRO collection and use in their practices. RISE LC learning sessions focused on improving communication around PROs with patients and enhancing shared decision-making in treatment plans. During the coronavirus disease 2019 (COVID-19) pandemic, the RISE LC pivoted to adapt PRO tools for telehealth.

Results: At baseline, all responding sites (n = 15) had established workflows for collecting PROs. Most sites used paper forms alone. PRO documentation in electronic health records was variable, with only half of the sites using structured data fields. To standardize and improve the use of PROs, participants iteratively developed a Clinical Disease Activity Index-based RA Disease Activity Communication Tool to solicit treatment goals and improve shared decision-making across sites. The COVID-19 pandemic necessitated developing a tool to gauge PROs via telehealth.

Conclusion: The RISE LC is a continuous, structured method for implementing strategies to improve PRO collection and use in rheumatological care, initially adapting from the Learning Collaborative model and extending to include features of a learning network. Future directions include measuring the impact of standardized PRO collection and discussion on shared decision-making and RA outcomes.

Citing Articles

Achieving reliable patient reported outcomes collection to measure health care improvement in a learning health network: lessons from pediatric rheumatology care and outcomes improvement network.

Pan N, Morgan E, Ryan M, Gottlieb B, Harris J, Lee T Front Pediatr. 2025; 12():1443426.

PMID: 39845456 PMC: 11753412. DOI: 10.3389/fped.2024.1443426.


Barriers to, Facilitators of, and Interventions to Support Treat-to-Target Implementation in Rheumatoid Arthritis: A Systematic Review.

Gossec L, Bessette L, Xavier R, Favalli E, Ostor A, Buch M Arthritis Care Res (Hoboken). 2024; 76(12):1626-1636.

PMID: 39090845 PMC: 11605793. DOI: 10.1002/acr.25408.


Using the technology acceptance model to assess clinician perceptions and experiences with a rheumatoid arthritis outcomes dashboard: qualitative study.

Nasrallah C, Wilson C, Hamblin A, Young C, Jacobsohn L, Nakamura M BMC Med Inform Decis Mak. 2024; 24(1):140.

PMID: 38802865 PMC: 11129391. DOI: 10.1186/s12911-024-02530-2.


Future challenges in rheumatology - is telemedicine the solution?.

de Thurah A, Marques A, de Souza S, Crowson C, Myasoedova E Ther Adv Musculoskelet Dis. 2022; 14:1759720X221081638.

PMID: 35321119 PMC: 8935581. DOI: 10.1177/1759720X221081638.


Implementing a Treat-to-Target Approach for Rheumatoid Arthritis During the COVID-19 Pandemic: Results of a Virtual Learning Collaborative Program.

Solomon D, Pincus T, Shadick N, Stratton J, Ellrodt J, Santacroce L Arthritis Care Res (Hoboken). 2022; 74(4):572-578.

PMID: 35119779 PMC: 9011823. DOI: 10.1002/acr.24830.

References
1.
Hulen E, Ervin A, Schue A, Evans-Young G, Saha S, Yelin E . Patient goals in rheumatoid arthritis care: A systematic review and qualitative synthesis. Musculoskeletal Care. 2016; 15(4):295-303. PMC: 5471121. DOI: 10.1002/msc.1173. View

2.
Singh J, Furst D, Bharat A, Curtis J, Kavanaugh A, Kremer J . 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res (Hoboken). 2012; 64(5):625-39. PMC: 4081542. DOI: 10.1002/acr.21641. View

3.
Britto M, Fuller S, Kaplan H, Kotagal U, Lannon C, Margolis P . Using a network organisational architecture to support the development of Learning Healthcare Systems. BMJ Qual Saf. 2018; 27(11):937-946. PMC: 6225794. DOI: 10.1136/bmjqs-2017-007219. View

4.
Liu L, Garrett S, Li J, Ragouzeos D, Berrean B, Dohan D . Patient and clinician perspectives on a patient-facing dashboard that visualizes patient reported outcomes in rheumatoid arthritis. Health Expect. 2020; 23(4):846-859. PMC: 7495065. DOI: 10.1111/hex.13057. View

5.
Solomon D, Losina E, Lu B, Zak A, Corrigan C, Lee S . Implementation of Treat-to-Target in Rheumatoid Arthritis Through a Learning Collaborative: Results of a Randomized Controlled Trial. Arthritis Rheumatol. 2017; 69(7):1374-1380. PMC: 5489379. DOI: 10.1002/art.40111. View